Publications scientifiques sur les diagnostics non invasifs BioPredictive
Études évaluées par les pairs validant les diagnostics sanguins BioPredictive pour les maladies du foie — des cohortes pionnières aux méta-analyses à long terme.
5/435
Résultats pour
“Chronic liver diseases (CLDs)”
-
Physicians' practices for diagnosing liver fibrosis in chronic liver diseases: a nationwide, Canadian survey.
…assessment of liver fibrosis in patients with chronic liver diseases. ### Methods Hepatologists…
-
The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases.
…be influenced by aetiology of chronic liver disease (CLD) and the stages…
-
Study of FibroTest and hyaluronic acid biological variation in healthy volunteers and comparison of serum hyaluronic acid biological variation between chronic liver diseases of different etiology and fibrotic stage using confidence intervals.
…and chronic liver disease patients stratified by etiology and liver fibrosis stage…
-
Prospective validation of ELF test in comparison with Fibroscan and FibroTest to predict liver fibrosis in Asian subjects with chronic hepatitis B.
### Background And Aims Liver stiffness measurement (LSM) and FibroTest (FT) are frequently…
-
Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection
…treatment of persons living with chronic hepatitis B (CHB) infection, and complement…
Affichage de la liste complète des résultats. La page est rendue côté serveur et non paginée.